GBI Research, the leading business intelligence provider, has released its latest research, 'Gastrointestinal Therapeutics in Major Developed Markets', which provides insights into three gastrointestinal therapeutic indications in the major developed markets of the US, the UK, France, Germany, Italy, Spain, Japan and Canada.
More...
More...